Skip to content
  • HOME
  • CONTACT US
  • CAREERS
  • ONLINE TRADING PORTAL
  • English
  • 中文
Crosby

Crosby

Menu

  • NEWS & ANNOUNCEMENTS
    • SHOW ALL
    • NEWS
    • ANNOUNCEMENT
    • RESEARCH
    • EVENTS
  • WHAT WE DO
    • SALES & TRADING
    • CORPORATE FINANCE
    • ASSET MANAGEMENT
    • WEALTH MANAGEMENT
  • ABOUT US
    • THE FIRM
    • HISTORY
    • TRANSACTIONS
    • SOCIAL RESPONSIBILITY

    RESEARCH

    CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)

    CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)

    25 Mar 2024 According to Reuters, China has introduced guidelines to phase out US microprocessors from Intel and AMD from government personal computers and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft’s Windows operating

    Crosby_research March 25, 2024March 25, 2024 RESEARCH Read more

    CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise

    CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise

    25 Mar 2024 After four consecutive declines of its semi-annual revenue, Sunny reported a turnaround of 2H23 revenue with 7.3% YoY growth to Rmb17,403m, driven by HLS/HCM shipment growth of 21.6%/37.3% YoY. GPM in 2H23 shrunk by 4.9ppt YoY to

    Crosby_research March 25, 2024March 25, 2024 RESEARCH Read more

    CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio

    CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio

    25 Mar 2024 Tai Hing’s FY23 revenue increased by 20.1% YoY to HK$3.21bn, with revenues from HK & Macau/China rose by 24.1%/1.6% YoY to HK$2.72bn/HK$0.49bn, benefiting from the reopening of the Chinese Mainland/HK border and promotional activities by HK Govt

    Crosby_research March 25, 2024March 25, 2024 RESEARCH Read more

    CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23

    CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23

    21 Mar 2024 Vincent Medical’s FY23 turnover (VM) amounted to HK$718.0m, representing a YoY increase of 14.1%. The increase is mainly driven by the increase in orders from the imaging disposable products segment, coupled with the rebound in sales of

    Crosby_research March 21, 2024March 21, 2024 RESEARCH Read more

    CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst

    CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst

    21 Mar 2024 Xiaomi reported 4Q23 results, with its revenue up 10.9% YoY to Rmb73.2bn, in which its YoY growth accelerated from 0.6% in 3Q23. After seven consecutive quarters’ of shipment decline, smartphone revenue strongly rebounded by 20.6% YoY to

    Crosby_research March 21, 2024March 21, 2024 RESEARCH Read more

    CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability

    CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability

    19 Mar 2024 Xtep’s FY23 revenue was up by 10.9% YoY to Rmb14,346m, mainly driven by i) steady growth of 7.4% YoY from core brand Xtep to Rmb11,947m due to the robust demand of running products, and continual growth from

    Crosby_research March 19, 2024 RESEARCH Read more

    CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24

    CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24

    19 Mar 2024 The company reported a 14.8% YoY increase in topline to Rmb3,544m in FY23 on the back of normalization of store operations post pandemic. Particularly, 2H23 reported a stronger growth at 21.6% YoY compared to 1H23. GPM was

    Crosby_research March 19, 2024March 19, 2024 RESEARCH Read more

    CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement

    CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement

    18 Mar 2024 Following the positive profit alert issued in Feb, it is no surprise that Wasion did indeed deliver a set of spectacular set of FY23 results. Its FY23 NP surged by 61.0% YoY to Rmb521.2m on the back

    Crosby_research March 18, 2024 RESEARCH Read more

    CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage

    CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage

    18 Mar 2024 FY23 revenue slightly increased by 1.9% YoY to HK$3,873m, mainly supported by a 38% YoY sales increase in HK/Macau market to HK$380m on the back of the rise in tourist arrivals, while markets in Mainland China/ Taiwan/

    Crosby_research March 18, 2024March 18, 2024 RESEARCH Read more

    CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments

    CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments

    14 Mar 2024 FY23 revenue was up 21.0% YoY to Rmb8.4bn, with core brand retail value up by low-teens/low-teens/15%/>20% YoY and that of 361º Kids up by 20-25%/low-teens/25-30%/40% YoY in 1Q/2Q/3Q/4Q. GPM was up by 0.6ppt YoY to 41.1%, with

    Crosby_research March 14, 2024 RESEARCH Read more
    • « Previous
    • Next »

    NEWS & ANNOUNCEMENTS

    • Show All
    • News
    • Announcement
    • Research
    • Events

    WHAT WE DO

    • Sales & Trading
    • Corporate Finance
    • Asset Management
    • Wealth Management

    ABOUT US

    • The Firm
    • History
    • Transactions
    • Social Responsibility
    Copyright © 2025 Crosby. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.